Minerva Neurosciences annual free cash flow
2013
2014
2017
2022
Minerva Neurosciences Free Cash Flow (FCF) History (NERV)
Minerva Neurosciences reported −$24.7M in free cash flow for fiscal 2022.
View full Minerva Neurosciences company overviewMinerva Neurosciences free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2022 | 2022-12-31 | −$24.7M | — | — | — |
| 2017 | 2017-12-31 | $3.0M | — | — | — |
| 2014 | 2014-12-31 | −$36.0M | −$33.8M | — | — |
| 2013 | 2013-12-31 | −$2.2M | — | — | — |
Minerva Neurosciences free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from $3.0M to −$24.7M, a net decrease of $27.7M.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Minerva Neurosciences source filings ↗